AI assistant
Sending…
Apyx Medical Corp — Director's Dealing 2021
Mar 8, 2021
34303_dirs_2021-03-08_6cc3ab29-7fb4-4742-82d0-654c3b1c9e56.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Apyx Medical Corp (APYX)
CIK: 0000719135
Period of Report: 2021-03-05
Reporting Person: Geraghty Michael (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-05 | Common Stock | M | 7500 | $2.81 | Acquired | 7500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-05 | Stock Option (Option to Buy) | $2.81 | X | 7500 | Disposed | 2021-03-18 | Common Stock (7500.0) | Direct |
Footnotes
F1: The transactions reported reflect the exercise of stock options.
More from Apyx Medical Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 11
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Director's Dealing
2026
Mar 17
Annual Report
2026
Mar 10
Regulatory Filings
2026
Mar 10
Major Shareholding Notification
2026
Feb 13